The Vivo X200 Ultra is said to ditch a 1-inch camera sensor from the Vivo X100 Ultra. The company plans to use a slightly ...

Vivo has already unveiled its most powerful smartphone – X200 series – in China. The company has now officially teased the global launch of the X200 series. As per the new teaser, the X200 ...

The Vivo V40e has a 6.77-inch FHD+ Curved AMOLED display with a 120Hz refresh rate. Powered by the MediaTek Dimensity 7300 SoC, the Vivo V40e packs a 5,500 mAh battery with 80W wired fast charging ...

Vivo S1 Pro is an undeniable beauty with a sleek and stylish look, the device feels premium due to its immersive features’ despite the fact that it is a mid-range smartphone. A well-rounded smart ...

The vivo X200 and X200 Pro, unveiled earlier this week, are now on sale in China through vivo's official Chinese website. The vivo X200 Pro comes in four colors and four memory options - 12GB ...

Hey there, vivo X200 Pro! We've spent some time with this gem of a cameraphone over at its launch event but we now have it at the office and it's ready for a review! The X200 Pro ships with a ...

vivaCT 40 is a fast and flexible in vivo microCT for preclinical studies. The low X-ray dose allows serial measurements of individuals. Whole-body scans or scans from selected regions of mice can ...

Just last week, Vivo unveiled the Vivo X200 series of flagship smartphones in its home market of China. These devices pack cutting edge technology and various AI powered features. But now ...

To recall, the Vivo X100 and X100 Pro featured the Dimensity 9300 chipset, whereas the X100 Ultra came with the Snapdragon 8 Gen 3 chip. The company may likely apply the same strategy to the Ultra ...

VIVO can provide such information and during this procedure VIVO was able to identify a more precise location than traditional methods alone. Highlights from this procedure include: VIVO was a ...

INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK cells in the patient’s body to target CD20-expressing malignant B cells Interim ...